Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: J Thromb Thrombolysis

Search In Journal Title:

Abbravation: Journal of Thrombosis and Thrombolysis

Search In Journal Abbravation:

Publisher

Springer US

Search In Publisher:

DOI

10.1016/0304-3894(95)00025-p

Search In DOI:

ISSN

1573-742X

Search In ISSN:
Search In Title Of Papers:

Association between sleep condition and arterial s

Authors: Xia Cao Jiansong Zhou Hong Yuan Zhiheng Chen
Publish Date: 2016/03/31
Volume: 42, Issue: 1, Pages: 127-134
PDF Link

Abstract

Nonalcoholic fatty liver NAFLD usually has worse cardiovascular risk factors Given the potential association between deterioration of sleep and arterial stiffness we aim to investigate the association between deterioration of sleep and arterial stiffness in a middleaged Chinese population with NAFLD In this crosssectional study 15372 Chinese aged 40–60 years who participated in periodic health checkups in central south China were included Selfreported sleep duration and sleep quality anthropometric biochemical and liver ultrasound scan were analyzed and brachialankle pulse wave velocity baPWV was used as the indicator of arterial stiffness Poor sleep quality was found to be associated with increased arterial stiffness with odds ratios and 95  confidence intervals CIs of 228 95  CI 153–338 compared with good sleep quality Using sleep duration ≥ 8 h as the reference there was no significant association between sleep duration of ≤ 6 or 6–8 h and arterial stiffness after multivariableadjusted In additional analyses further investigation of the association of different combinations of sleep duration and quality in relation to arterial stiffness indicated participants with poor sleep quality and sleep duration ≤ 6 h were more likely to have arterial stiffness than those with good quality sleep who sleep for ≥ 8 h OR 259 95  CI 158–424 The present study indicates that short sleep duration poor sleep quality in individuals with NAFLD correlate with increased arterial stiffnessWe thank Chang Liu for his help in programming and statistical analyses as well as all participants for their contribution This work was supported in part by a grant from Key Science and Technology Projects in Hunan Province 2014SK3062 and a grant from Science and Technology Plan Projects 2013BAI04B00


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. The inhibition in tumor necrosis factor-α-induced attenuation in endothelial thrombomodulin expression by carvedilol is mediated by nuclear factor-κB and reactive oxygen species
  2. Comparison of platelet inhibition by prasugrel versus ticagrelor over time in patients with acute myocardial infarction
  3. Does supervised exercise after deep venous thrombosis improve recanalization of occluded vein segments? A randomized study
  4. Anticoagulation in the management of venous thromboembolism in the cancer patient
  5. In vitro shear stress modulates antithrombogenic potentials of human endothelial progenitor cells
  6. Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease
  7. Role of thrombophilia testing: con
  8. Venous thromboembolism and cancer: a systematic review
  9. Dabigatran-associated subdural hemorrhage: using thromboelastography (TEG ® ) to guide decision-making
  10. Proceedings of the 10th National Conference on Anticoagulant Therapy
  11. Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist device
  12. The relationship between gender and age with monocyte tissue factor expression
  13. Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability
  14. A comparison of direct thrombin inhibitors in the treatment of heparin-induced thrombocytopenia: a single institution experience
  15. US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins
  16. Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: an observational study
  17. Abnormal asymmetric dimethylarginine/nitric oxide balance in patients with documented coronary artery disease: relation to renal function and homocysteine
  18. Tailoring clopidogrel dose according to multiple electrode aggregometry decreases the rate of ischemic complications after percutaneous coronary intervention
  19. Cardiovascular risk factors and outcome in patients with retinal vein occlusion
  20. Impact of type of thrombolytic agent on in-hospital outcomes in ST-segment elevation myocardial infarction patients in the Middle East
  21. Prognostic significance of multidetector computed tomography in normotensive patients with pulmonary embolism: rationale, methodology and reproducibility for the PROTECT study
  22. Increased platelet activation in patients with slow coronary flow
  23. Biomarkers of deep venous thrombosis
  24. Thromboembolic complications following a first isolated episode of superficial vein thrombosis: a cross-sectional retrospective study
  25. The impact of factor Xa inhibition on axial dependent arterial thrombus formation triggered by a tissue factor rich surface
  26. New oral Xa and IIa inhibitors: updates on clinical trial results
  27. Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study
  28. Anti-coagulant activity of a metalloprotease: further characterization from the Indian cobra ( Naja naja ) venom
  29. Evaluation of the Alere D-dimer test for point of care testing
  30. Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves
  31. Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial
  32. Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism
  33. Methylenetetrahydrofolate reductase (MTHFR) C677T genetic polymorphism and late infarct-related coronary artery patency after thrombolysis
  34. Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis?
  35. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait

Search Result: